Nu-Med Plus (NUMD) 10-Q 16 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	Nov. 16, 2020	Sep. 30, 2020
Details
Registrant CIK		0001543637
Fiscal Year End		--12-31
Registrant Name		Nu-Med Plus, Inc.
SEC Form		10-Q
Period End date		Sep. 30, 2020
Tax Identification Number (TIN)		45-3672530
Number of common stock shares outstanding	50,228,469
Filer Category		Non-accelerated Filer
Current with reporting		Yes
Interactive Data Current		Yes
Shell Company		false
Small Business		true
Emerging Growth Company		true
Ex Transition Period		false
Entity File Number		000-54808
Entity Incorporation, State or Country Code		UT
Entity Address, Address Line One		455 East 500 South, Suite 203
Entity Address, City or Town		Salt Lake City
Entity Address, State or Province		UT
Entity Address, Postal Zip Code		84111
City Area Code		801
Local Phone Number		746-3570
Entity Listing, Par Value Per Share	$ 0.001
Amendment Flag		false
Document Fiscal Year Focus		2020
Document Fiscal Period Focus		Q3
Document Quarterly Report		true
Document Transition Report		false

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash	$ 31,498	$ 7,079
Prepaid expense	592,807	6,879
Total current assets	624,305	13,958
Long-term assets
Property and equipment, net	14,281	23,425
Operating lease right-of-use of assets	10,975	8,396
Total long-term assets	25,256	31,821
Total assets	649,561	45,779
Current liabilities
Accounts payable	30,113	39,820
Accounts payable - related party	20,000	14,085
Accrued expenses	10,975	9,579
Accrued interest - related party	116,339	114,231
Operating lease liability	10,975	8,396
Convertible Promissory Notes - Related party	230,100	230,100
Total current liabilities	418,502	416,211
Long-term liabilities
Note payable	9,384	0
Long-term liabilities	9,384	0
Total liabilities	427,886	416,211
Commitments and contingencies	0	0
Stockholders' equity (deficit)
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value; 90,000,000 authorized; 50,228,469 and 44,476,625 shares issued and outstanding, as of September 30, 2020 and December 31, 2019, respectively.	50,229	44,477
Additional paid-in capital	8,219,893	5,849,784
Stock subscription payable	197,412	465,541
Accumulated deficit	(8,245,859)	(6,730,234)
Total stockholders' deficit	221,675	(370,432)
Total liabilities and stockholders' deficit	$ 649,561	$ 45,779

Condensed Balance Sheets - Pare

Condensed Balance Sheets - Parenthetical - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	90,000,000	90,000,000
Common Stock, Shares, Issued	50,228,469	44,476,625
Common Stock, Shares, Outstanding	50,228,469	44,476,625

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Details
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses
General and administrative expense	13,708	10,162	51,693	60,014
Payroll expense	67,465	70,476	638,797	196,456
Rent expense	4,689	4,570	14,068	13,767
Professional and consulting fees	360,848	57,871	789,814	533,159
Depreciation expense	3,048	3,134	9,144	10,330
Total operating expenses	449,758	146,213	1,503,517	813,726
Operating Loss	(449,758)	(146,213)	(1,503,517)	(813,726)
Other expense
Interest expense	(4,066)	(4,363)	(12,108)	(13,229)
Total other expense	(4,066)	(4,363)	(12,108)	(13,229)
Income tax expense	0	0	0	0
Net loss	$ (453,824)	$ (150,576)	$ (1,515,625)	$ (826,955)
Basic and diluted earnings (loss) per share	$ (0.01)	$ 0	$ (0.03)	$ (0.02)
Weighted average common shares outstanding - basic and diluted	50,263,252	45,962,847	48,454,879	45,410,048

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Other Additional Capital	Retained Earnings	Total
Common Stock, Shares, Outstanding		41,274,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 0	$ 41,274	$ 4,851,487	$ 849,175	$ (5,693,409)	$ 48,527
Stock issued for cash		200,000
Stock issued for cash	$ 0	$ 200	49,800	0	0	50,000
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2018	0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018		41,274,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 0	$ 41,274	4,851,487	849,175	(5,693,409)	48,527
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 41,514	4,961,247	849,175	(6,121,604)	(224,668)
Common Stock issued under subscription		40,000
Proceeds from issuance of common stock	0	$ 40	9,960	(10,000)	0	0
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	$ 0	$ 0	0	0	(428,195)	(428,195)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019		$ 41,514	4,961,247	849,175	(6,121,604)	$ (224,668)
Stock issued for cash						200,000
Stock issued for cash						$ 50,000
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2018	0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018		41,274,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 0	$ 41,274	4,851,487	849,175	(5,693,409)	48,527
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 41,514	5,061,247	1,114,191	(6,520,364)	(303,412)
Stock issued for accrued interest on convertible note						0
Stock issued for services performed						0
Net income (loss)						(826,955)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019	0	$ 41,514	5,061,247	1,114,191	(6,520,364)	(303,412)
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ 41,514	4,961,247	849,175	(6,121,604)	(224,668)
Stock subscription payable - cash	0	$ 0	0	55,000	0	55,000
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019		$ 41,514	4,961,247	849,175	(6,121,604)	(224,668)
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 41,514	5,011,247	1,009,773	(6,369,788)	(307,254)
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	0	0	0	0	(248,184)	(248,184)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	0	41,514	5,011,247	1,009,773	(6,369,788)	(307,254)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	41,514	5,011,247	1,009,773	(6,369,788)	(307,254)
Stock subscription payable - cash	0	$ 0	0	115,598	0	115,598
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 41,514	5,061,247	1,114,191	(6,520,364)	(303,412)
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	0	$ 0	0	0	(150,576)	(150,576)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019	0	$ 41,514	5,061,247	1,114,191	(6,520,364)	(303,412)
Common Stock, Shares, Outstanding		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 41,514	5,061,247	1,114,191	(6,520,364)	(303,412)
Stock subscription payable - cash	0	$ 0	0	104,418	0	$ 104,418
Common Stock, Shares, Outstanding		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 0	$ 44,477	5,849,784	465,541	(6,730,234)	$ (370,432)
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2019	0					0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 0	$ 44,477	5,849,784	465,541	(6,730,234)	$ (370,432)
Common Stock, Shares, Outstanding		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 44,447	5,899,784	571,980	(6,883,568)	$ (367,327)
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	$ 0	$ 0	0	0	(153,334)	(153,334)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020		$ 44,447	5,899,784	571,980	(6,883,568)	$ (367,327)
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2019	0					0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 0	$ 44,477	5,849,784	465,541	(6,730,234)	$ (370,432)
Common Stock, Shares, Outstanding		50,228,469				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 50,229	8,219,893	197,412	(8,245,889)	$ 221,675
Common Stock issued under subscription						2,706,844
Stock issued for accrued interest on convertible note						1,000,000
Stock issued for accrued interest on convertible note						$ 10,000
Stock issued for prepaid services						$ 940,500
Stock issued for services performed						500,000
Stock issued for services performed						$ 798,650
Net income (loss)						$ (1,515,625)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2020		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2020	0	$ 50,229	8,219,893	197,412	(8,245,889)	$ 221,675
Common Stock, Shares, Outstanding		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ 44,447	5,899,784	571,980	(6,883,568)	(367,327)
Stock subscription payable - cash	0	$ 0	0	106,439	0	106,439
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2020		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020		$ 44,447	5,899,784	571,980	(6,883,568)	(367,327)
Common Stock, Shares, Outstanding		50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 50,229	8,132,393	21,000	(7,792,035)	411,587
Common Stock issued under subscription		2,706,844
Proceeds from issuance of common stock	0	$ 2,707	674,004	(676,711)	0	0
Stock issued for accrued interest on convertible note		1,000,000
Stock issued for accrued interest on convertible note	0	$ 1,000	9,000	0	0	10,000
Stock issued for prepaid services		1,400,000
Stock issued for prepaid services	0	$ 1,400	939,100	0	0	940,500
Stock issued for services performed		645,000
Stock issued for services performed	0	$ 645	610,505	0	0	611,150
Net income (loss)	0	$ 0	0	0	(908,467)	(908,467)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020		50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	0	$ 50,229	8,132,393	21,000	(7,792,035)	411,587
Common Stock, Shares, Outstanding		50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 50,229	8,132,393	21,000	(7,792,035)	411,587
Stock subscription payable - cash	0	$ 0	0	125,731	0	$ 125,731
Common Stock, Shares, Outstanding		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 50,229	8,219,893	197,412	(8,245,889)	$ 221,675
Stock issued for services performed	0	0	87,500	0	0	87,500
Net income (loss)	0	$ 0	0	0	(453,824)	$ (453,824)
Common Stock, Shares, Outstanding, Ending Balance at Sep. 30, 2020		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2020	0	$ 50,229	8,219,893	197,412	(8,245,889)	$ 221,675
Common Stock, Shares, Outstanding		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	0	$ 50,229	8,219,893	197,412	(8,245,889)	$ 221,675
Stock subscription payable - cash	$ 0	$ 0	$ 0	$ 126,412	$ 0	$ 126,412

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (1,515,625)	$ (826,955)
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Depreciation	9,144	10,330
Amortization of prepaid consulting	356,807	0
Amortization of right of use asset	9,355	8,064
Stock issued for services performed	798,650	0
Stock-based compensation	0	356,250
(Increase) decrease in prepaid expenses	(2,235)	8,512
(Increase) decrease in operating lease liability	(9,355)	(8,064)
Increase (decrease) in accounts payable	(9,707)	9,150
Increase (decrease) in related party payables	5,915	5,034
Increase (decrease) in accrued expense	13,504	(4,997)
Net cash used in operating activities	(343,547)	(442,676)
Cash flows from investing activities:
Net cash used in investing activities	0	0
Cash flows from financing activities
Proceeds from stock subscriptions payable	358,582	275,016
Proceeds from notes payable	9,384	0
Proceeds from issuance of common stock	0	50,000
Payments on financing lease	0	(8,015)
Net cash provided by financing activities	367,966	317,001
Net increase (decrease) in cash	24,419	(125,675)
Cash at beginning of period	7,079	167,513
Cash at end of period	31,498	41,838
Supplemental schedule of cash flow information
Cash paid for interest	0	1,175
Cash paid for income tax	0	0
Common stock issued for subscription payable	676,711	10,000
Right-of-use operating lease assets obtained in exchange for operating lease liabilities	11,934	19,482
Conversion of accrued interest for common stock	10,000	0
Common stock issued for prepaid services	$ 940,500	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2020
Notes
Organization and Description of Business	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The recent COVID 19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our contract developers. The wide ranging effects on the World Wide business market has led to a closure or partial closure of firms we are relying on in our product development. As a result their work on our project has been slowed. While we cannot predict when the influence of the Pandemic will end, we trust businesses will be able to open and expand activities to their former levels and increase following a return to normal operations. a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020. The Financial Accounting Standards Board (“FASB”) issued new guidance for the recognizing and reporting of revenue, ASU 2014-09, Revenue from Contracts with Customers (“ASC606”). The effective date for implementation for public companies was January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. 2. 3. 4. 5. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606. c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures. e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years. f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis. g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 589,648 and 4,453,012 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2020 and 2019, respectively. Three months ended September 30, 2020 Three months ended September 30, 2019 Nine months ended September 30, 2020 Nine months ended September 30, 2019 Net loss (numerator) $(453,824) $(150,576) $(1,515,625) $(826,955) Shares (denominator) 50,263,252 45,962,847 48,753,660 45,410,048 Net loss per share amount – basic and diluted $(0.01) $(0.00) $(0.03) $(0.02) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of September 30, 2020 and 2019 there were 34,643,900 and 34,026,500, respectively, potential dilutive shares that needed to be considered as common share equivalents. As of September 30, 2020 and 2019 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive. h. Concentrations and Credit Risk The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan. i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date k. Leases The Company accounts for all leases in accordance with ASC 842, Leases l. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2020
Notes
GOING CONCERN	NOTE 2 - GOING CONCERN The Company acknowledges that the funds on hand as of September 30, 2020, will not be sufficient to enable it to execute its business plan and will require funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through November 30, 2020. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2020
Notes
Property and Equipment	NOTE 3 – PROPERTY AND EQUIPMENT Property and equipment and related accumulated depreciation consisted of the following at September 30, 2020, and December 31, 2019: September 30, 2020 December 31, 2019 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (76,087) (66,943) Total Fixed Assets $ 14,281 $ 23,425 Depreciation expense for the nine months ended September 30, 2020 and 2019 was $9,144 and $10,330, respectively.

Preferred and Common Stock

Preferred and Common Stock	9 Months Ended
	Sep. 30, 2020
Notes
Preferred and Common Stock	NOTE 4 - PREFERRED STOCK On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at September 30, 2020. NOTE 5 - COMMON STOCK Stock Subscription Payable At September 30, 2020 and December 31, 2019, the Company had $197,412 and $465,541, respectively, in stock subscriptions payable for which it is obligated to issue 589,648 and 1,862,164 shares of restricted common stock, respectively, pursuant to separate subscription agreements. April 2020 Subscription Agreement In April 2020, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. The agreement expires on December 31, 2021. The Company received $229,518 under this agreement in the nine months ended September 30, 2020. At the date of this report 328,424 shares of common stock have been issued, leaving a balance of 589,648 shares to be issued. As of September 30, 2020 a total of 681,928 shares of common stock for $170,482 are available for purchase under this agreement. July 2019 Subscription Agreement In July 2019, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $250,000 in shares of common stock at $0.25 per share. The agreement expires on December 31, 2020. The Company received $129,064 under this agreement during 2020 and $120,936 in 2019. In June 2020 the Company issued 1,000,000 shares of common stock in settlement of its obligations under this agreement. September 2017 Subscription Agreement In September 2017, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. This agreement expired on August 30, 2018. The Company received $153,070 under this agreement during 2018 and $246,930 during 2019. In June 2020 the Company issued 1,600,000 shares of restricted common stock in settlement of its obligations under this agreement. In the nine months ended September 30, 2020 the Company issued a total of 5,751,844 shares of common stock. Of the total 2,706,844 was issued in settlement of stock subscriptions payable, 1,000,000 shares were issued from the conversion of accrued interest on notes payable, and 2,245,000 was issued for services performed and services to be performed. Common Stock Issued for Services See also Common Stock Issued for Services below. Common Stock Issued for Cash During the nine months ending September 30, 2019, the Company issued 200,000 shares of restricted common stock for $50,000 to an unrelated investor. Common Stock Issued for conversion of liabilities During the nine months ended September 30, 2020, the Company issued 1,000,000 shares of restricted common stock in exchange for the conversion of $10,000 of accrued interest on notes payable. Common Stock Issued to Officer On February 14, 2018 the Company announced that the consulting agreement with the Chief Financial Officer (Mr. Merrell) was terminated effective December 31, 2017, and that a new agreement was entered into effective January 1, 2018 under which Mr. Merrell would receive 2,000,000 shares of restricted common stock, vesting at 500,000 shares per year, for his service. The term of the agreement is for one year, which term automatically renews for one year extensions up to four years unless terminated by either party with 30 days written notice. The Company issued all 2,000,000 shares to Mr. Merrell on August 20, 2018. Any common shares not earned during the four year period are to be returned or cancelled. A charge will be made each quarter as the shares are earned under the provisions of the agreement until such time as all shares have been earned. A charge of $150,000 and $150,000 was recorded for the nine months ended September 30, 2020 and 2019, respectively. In June 2020 Mr. Merrell was issued an additional 500,000 shares which vested at issuance, resulting in a $435,000 stock-based compensation charge recorded in the nine-month period ended September 30, 2020. Common Stock Issued for Services During the nine months ended September 30, 2020 the Company issued 1,545,000 shares of restricted common stock to consultants for services performed and/or to be performed. The issuances were valued at $1,066,650 and of that amount, $940,500 was recorded as prepaid assets and the remaining $126,150 recorded as stock-based compensation. The Company subsequently amortized $356,807 of the prepaid expenses as professional and consulting fees. As of September 30, 2020, the remaining prepaid balance of $583,693 remains to be amortized as the services are performed. In September 2020, the Company entered into a consulting agreement with Waterside Capital Advisers, Inc. to raise capital for the Company and provide other consulting services. Under the terms of the agreement, 50,000 shares of common stock were to be issued upon signing the agreement, 75,000 shares of common stock were to be issued 30 days after the signing date and an additional 75,000 shares are to be issued 60 days after the signing date. Accordingly, the Company valued the shares at $200,000 of which $50,000 has been recorded as common stock payable as of September 30, 2020. The Company recorded $87,500 in stock-based compensation to Waterside during the period ended September 30, 2020. The remaining balance of $112,500 will be expensed in the final quarter of 2020. Further, the agreement contains a long-term incentive whereby an additional 2,000,000 shares of common stock may be earned by the consultant upon the achieving of certain milestones as detailed in the agreement. In September 2018, the Company issued 650,000 shares of stock to two consultants. Of these shares, 150,000 were issued under a consulting contract for services rendered and vested upon issue and 500,000 shares of restricted stock were issued to a consultant for services rendered and to be rendered through June 1, 2019. The common stock was valued at $639,000, of which $432,750 was expensed during the year ended December 31, 2018. The remaining balance of $206,250 was expensed during the year ended December 31, 2019.

Convertible Notes and Derivativ

Convertible Notes and Derivative Liability	9 Months Ended
	Sep. 30, 2020
Notes
Convertible Notes and Derivative Liability	NOTE 6 – PROMISSORY NOTES $100,000 Convertible Promissory Note On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided during the period April 1, 2012 through March 31, 2013. The note is due on demand, had an annual interest of 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion. On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest. As of September 30, 2020 and December 31, 2019 interest accrued, but unpaid, was $54,427 and $47,899, respectively. At September 30, 2020 the balance of the note is $100,000, with $54,427 in accrued unpaid interest. $130,100 Convertible Promissory Note Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price. The balance of this note was $130,100 at September 30, 2020 and December 31, 2019 with the accrued interest balances of $63,674 and $65,861, respectively. During the nine-month period ended September 30, 2020, the Company received a request to convert $10,000 of interest accrued and unpaid to shares of restricted common stock. Under the conversion terms of the agreement 1,000,000 shares of restricted stock were issued. At September 30, 2020 the balance of the note is $130,100, with $63,674 of accrued unpaid interest. $9,384 Promissory Note The Company applied for and received a $9,384 loan under the Paycheck Protection Program administered by the Small Business Administration. The note bears an annual interest rate of 1% and has a maturity date of May 8, 2022. The terms of the loan provide that an application for forgiveness of the loan amount may be requested if the funds were used for payroll, medical insurance, rent and utilities. As all of the funds were used in the allowable categories, the Company will file an application for forgiveness as soon as the bank makes available the form for such request.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Notes
Commitments and Contingencies	NOTE 7 - COMMITMENTS AND CONTINGENCIES The Company has obligations under both a financing lease and operating lease, as detailed below. Operating Lease Obligations The Company entered into a lease for office space in February 2017 and has signed various extensions since the, the latest of which expired on August 20202. In August 2020 the Company extended the lease agreement through August 31, 2021 at a rate of $1,038 per month. Amortization of $9,355 was recorded as rent expense in the nine month period ended September 30, 2020, leaving an operating right-of-use asset at September 30, 2020 of $10,975 and an operating lease liability of $10,975. Cash payments of $9,343 were made for rent expense for the nine month period ended September 30, 2020. Obligations under this lease are as follows: 2020 2021 2022 Office lease $ 3,114 $ 8,305 $ - Upon the adoption of ASC 842, the calculation of our lease obligation using a discount rate of 8% resulted in an immaterial difference and therefore, no interest will be imputed on the lease obligation. There are eleven months remaining on the office lease, which terminates August 31, 2021. Consulting Agreement In September 2020, the Company entered into a consulting agreement with Waterside Capital Advisers, Inc. to raise capital for the Company and provide other consulting services. Under the terms of the agreement, 50,000 shares of common stock were to be issued upon signing the agreement, 75,000 shares of common stock were to be issued 30 days after the signing date and an additional 75,000 shares are to be issued 60 days after the signing date. Accordingly, the Company valued the shares at $200,000 of which $50,000 has been recorded as common stock payable as of September 30, 2020. The Company recorded $87,500 in stock-based compensation to Waterside during the period ended September 30, 2020. The remaining balance of $112,500 will be expensed in the final quarter of 2020. The agreement also provides that the consultant be paid $5,000 per month for services, which fee will be accrued until such time as the Company and consultant agree acceptable financing has been raised, at which point payment of all accrued but unpaid fees will be made. In accordance with the agreement a $2,500 consultant fee was accrued for the last half of September 2020. Further, the agreement contains a long-term incentive whereby an additional 2,000,000 shares of common stock may be earned by the consultant upon the achieving of certain milestones as detailed in the agreement. In June 2020, the Company entered into consulting agreements with Roger Gill and Peter Kristensen. Both of the agreements begin June 22, 2020 and run for a period of twelve months, terminating June 30, 2021. Under the terms of the agreements Mr. Gill will receive 500,000 shares of restricted common stock and Mr. Kristensen will receive 100,000 shares of restricted stock for their services. The fair-value of the stock was $565,500 and was recorded as a prepaid. During the nine months, the company amortized $153,382 of the prepaid expense. As of September 30, 2020, the remaining $412,118 was remaining in prepaid expenses, to be amortized over the term of the agreements. On March 15, 2020 the Company entered into a service agreement with Hanover International, Inc. to provide advisory services to the Company. The contract is a one year contract, but may be cancelled with thirty days notice any time after the 91 st day of the agreement. Hanover will receive a fee of $ 3,500 per month, from which fee it pays all of its expenses. In addition, Hanover will receive 750,000 shares of restricted common stock, earned in quarterly tranches of 187,500 shares, deemed earned and issuable after services are provided for each quarter. As of September 30, 2020 all of the shares to which the Company is obligated under this agreement have been issued, with the unearned portion included in prepaid expenses. The shares were issued at $ 0.50 per share for a total value of $ 375,000 . The amount has been recorded in prepaid expenses, with $ 203,425 of the total being expensed in the nine-month period ended September 30, 2020. The remaining prepaid amount of $ 171,575 will be amortized over the remaining life of the agreement.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Notes
Subsequent Events	NOTE 8 - SUBSEQUENT EVENTS The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that require disclosure as of the date of issuance.

Organization and Description _2

Organization and Description of Business (Policies)	9 Months Ended
	Sep. 30, 2020
Policies
Accounting Method	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The recent COVID 19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our contract developers. The wide ranging effects on the World Wide business market has led to a closure or partial closure of firms we are relying on in our product development. As a result their work on our project has been slowed. While we cannot predict when the influence of the Pandemic will end, we trust businesses will be able to open and expand activities to their former levels and increase following a return to normal operations. a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020.
Revenue Recognition	The Financial Accounting Standards Board (“FASB”) issued new guidance for the recognizing and reporting of revenue, ASU 2014-09, Revenue from Contracts with Customers (“ASC606”). The effective date for implementation for public companies was January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. 2. 3. 4. 5. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606.
Estimates	c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures.
Property and equipment	e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures exceeding $500 for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years.
Fair Value	f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis.
Earnings Per Share	g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 589,648 and 4,453,012 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2020 and 2019, respectively. Three months ended September 30, 2020 Three months ended September 30, 2019 Nine months ended September 30, 2020 Nine months ended September 30, 2019 Net loss (numerator) $(453,824) $(150,576) $(1,515,625) $(826,955) Shares (denominator) 50,263,252 45,962,847 48,753,660 45,410,048 Net loss per share amount – basic and diluted $(0.01) $(0.00) $(0.03) $(0.02) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of September 30, 2020 and 2019 there were 34,643,900 and 34,026,500, respectively, potential dilutive shares that needed to be considered as common share equivalents. As of September 30, 2020 and 2019 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive.
Concentration and Credit Risk	h. Concentrations and Credit Risk The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan.
Income Taxes	i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items	j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date
Leases	k. Leases The Company accounts for all leases in accordance with ASC 842, Leases
New Accounting Pronouncements	l. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

Organization and Description _3

Organization and Description of Business (Tables)	9 Months Ended
	Sep. 30, 2020
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	Three months ended September 30, 2020 Three months ended September 30, 2019 Nine months ended September 30, 2020 Nine months ended September 30, 2019 Net loss (numerator) $(453,824) $(150,576) $(1,515,625) $(826,955) Shares (denominator) 50,263,252 45,962,847 48,753,660 45,410,048 Net loss per share amount – basic and diluted $(0.01) $(0.00) $(0.03) $(0.02)

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2020
Tables/Schedules
Property, Plant and Equipment	September 30, 2020 December 31, 2019 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (76,087) (66,943) Total Fixed Assets $ 14,281 $ 23,425

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Tables/Schedules
Schedule of Future Minimum Lease Payments for Capital Leases	2020 2021 2022 Office lease $ 3,114 $ 8,305 $ -

Organization and Description _4

Organization and Description of Business (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Details
Stock Issued During Period, Shares, Period Increase (Decrease)	1,862,164			589,648	4,453,012
Net Income (Loss) Available to Common Stockholders, Basic		$ (453,824)	$ (150,576)	$ (1,515,625)	$ (826,955)
Weighted Average Number of Shares Outstanding, Basic		50,263,252	45,962,847	48,753,660	45,410,048
Basic and diluted earnings (loss) per share		$ (0.01)	$ 0	$ (0.03)	$ (0.02)
Dilutive Shares		34,643,900	34,026,500

GOING CONCERN (Details)

GOING CONCERN (Details)	9 Months Ended
	Sep. 30, 2020USD ($)
Details
Planned expenditures	$ 1,200,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Details
Property, Plant and Equipment, Gross	$ 90,368		$ 90,368		$ 90,368
Accumulated Depreciation	(76,087)		(76,087)		(66,943)
Property and equipment, net	14,281		14,281		$ 23,425
Depreciation expense	$ 3,048	$ 3,134	$ 9,144	$ 10,330

Preferred and Common Stock (Det

Preferred and Common Stock (Details) - USD ($)	Apr. 02, 2020	Dec. 31, 2019	Jul. 02, 2019	Dec. 31, 2018	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2018	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Sep. 02, 2017
Details
Preferred Stock, Shares Authorized		10,000,000			10,000,000			10,000,000							10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001			$ 0.001							$ 0.001		$ 0.001
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable		$ 465,541			$ 197,412			$ 197,412							$ 197,412		$ 465,541
Stock Issued During Period, Shares, Period Increase (Decrease)		1,862,164													589,648	4,453,012
400,000 Stock Subscription Amount															$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price	$ 0.25		$ 0.25																$ 0.25
400,000 Amount Used From Subscription															229,518		$ 246,930
Shares Issued Under $400,000 Stock Purchase Agreement	328,424
Shares Under $400,000 Stock Purchase Agreement	681,928
400,000 Amount Available From Subscription															170,482
250,000 Stock Subscription Amount															$ 250,000
250,000 Amount Used From Subscription								129,064			$ 120,936
Shares Under $250,000 Stock Purchase Agreement			1,000,000
400,000 Amount Used From Subscription In Prior Periods																		$ 153,070
Common Stock issued under subscription						1,600,000									2,706,844
Total Shares Issued															5,751,844
Stock issued for accrued interest on convertible note															1,000,000
Total Shares Issued for services performed and to be performed															2,245,000
Stock issued for cash																200,000
Stock issued for cash													$ 50,000			$ 50,000
Conversion of accrued interest for common stock									$ 10,000						$ 10,000	0
Merrell stock compensation															2,000,000
Stock issued for services performed						1,545,000	650,000								500,000
Merrell stock compensation Amount															$ 150,000	150,000
Merrell additional stock compensation															500,000
Merrell additional stock compensation Amount															$ 435,000
1545000 shares issued for services														$ 1,066,650
Stock issued for prepaid services									940,500						940,500
1545000 shares issued for services amount paid														126,150
Amortization of prepaid consulting					$ 356,807			356,807			0				356,807	0
1545000 shares issued for services amount balance														$ 583,693
WatersideCapitalAdvisersigningshares					50,000
WatersideCapitalAdviser30dayshares					75,000
WatersideCapitalAdviser60dayshares					75,000
WatersideCapitalAdvisersharevalue					$ 200,000
WatersideCapitalAdvisercommonstockpayableamount					50,000
Stock issued for services performed							$ 639,000	$ 87,500	$ 611,150	$ 50,000	$ 50,000	$ 50,000	$ 50,000		$ 798,650	$ 0
WatersideCapitalAdviserremainingbalance					$ 112,500
WatersideCapitalAdviserincentiveshares					2,000,000
Consulting stock compensation 1															150,000
Consulting stock compensation 2															500,000
Consulting expense		$ 206,250		$ 432,750	$ 2,500

Convertible Notes and Derivat_2

Convertible Notes and Derivative Liability (Details) - USD ($)	3 Months Ended	9 Months Ended
	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Nov. 12, 2012
Details
SCS convertible promissory note principal				$ 47,899	$ 100,000
SCS convertible promissory note interest rate		5.50%
SCS convertible promissory note conversion price		$ 0.01
SCS convertible promissory note interest		$ 54,427
130,100 convertible promissory note interest rate		8.00%
130,100 convertible promissory note conversion price		$ 0.01
130,100 convertible promissory note principal balace		$ 130,100
130,100 convertible promissory note accrued interest		63,674		65,861
Conversion of accrued interest for common stock	$ 10,000	$ 10,000	$ 0
Stock issued for accrued interest on convertible note		1,000,000
Note payable		$ 9,384		$ 0

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2018	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Aug. 31, 2020
Details
monthly office lease payment														$ 1,038
Amortization of right of use asset												$ 9,355	$ 8,064
Operating lease right-of-use of assets	$ 8,396		$ 10,975			$ 10,975						10,975
Operating lease liability	8,396		10,975			10,975						10,975
Operating Leases, Rent Expense, Net												9,343
Capital Leases, Future Minimum Payments Due, Next Twelve Months			3,114			3,114						3,114
Capital Leases, Future Minimum Payments Due in Two Years			$ 8,305			8,305						8,305
WatersideCapitalAdvisersigningshares			50,000
WatersideCapitalAdviser30dayshares			75,000
WatersideCapitalAdviser60dayshares			75,000
WatersideCapitalAdvisersharevalue			$ 200,000
WatersideCapitalAdvisercommonstockpayableamount			50,000
Stock issued for services performed					$ 639,000	$ 87,500	$ 611,150	$ 50,000	$ 50,000	$ 50,000	$ 50,000	798,650	$ 0
WatersideCapitalAdviserremainingbalance			112,500
Waterside compensation monthly payment												5,000
Consulting expense	$ 206,250	$ 432,750	$ 2,500
WatersideCapitalAdviserincentiveshares			2,000,000
Gill shares received in consulting agreement				500,000
Kristensen shares received in consulting agreement				100,000
Gill and Kristensen Consulting shares value total				$ 565,500
Gill and Kristensen Consulting shares amount amortized				153,382
Gill and Kristensen Consulting shares amount remaining				$ 412,118
Hanover compensation monthly payment												$ 3,500
Hanover total compensation shares												750,000
Hanover tranche compensation shares												187,500
Hanover price per share												$ 0.50
Hanover total value												$ 375,000
Hanover Amount Expensed												203,425
Hanoverremainingprepaid												$ 171,575